{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:22:48Z","timestamp":1770477768228,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancergeneticsjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.cancergencyto.2004.06.014","type":"journal-article","created":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T07:50:59Z","timestamp":1108713059000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clonal evolution with inv(11)(p15q22) and NUP98\/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia"],"prefix":"10.1016","volume":"157","author":[{"given":"Masahide","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kakihana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2004.06.014_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back","volume":"22","author":"Wong","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2013a new oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib4","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood-2003-11-3800","article-title":"High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome\u2013positive chronic phase chronic myeloid leukemia","volume":"103","author":"Kantarjian","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib5","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/sj.leu.2402269","article-title":"NUP98 gene fusions in hematologic malignancies","volume":"15","author":"Lam","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib7","first-page":"3079","article-title":"NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)","volume":"63","author":"Lahortiga","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib8","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood.V89.11.3936","article-title":"The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10","volume":"89","author":"Arai","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/geno.1996.0184","article-title":"A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23","volume":"33","author":"Savitsky","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V99.3.1097","article-title":"Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis","volume":"99","author":"Hussey","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib11","series-title":"An international system for human cytogenetic nomenclature","author":"ISCN","year":"1995"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib12","first-page":"160","article-title":"The inv(11) (p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98\u2013DDX10 and DDX10\u2013NUP98 fusion transcripts","volume":"69","author":"Ikeda","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/bbrc.1997.7480","article-title":"Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells","volume":"239","author":"Chin","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood.V70.5.1654.1654","article-title":"Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p\u2212;11p+), associated with myeloid leukemia with maturation","volume":"70","author":"Sato","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2169\/internalmedicine.39.412","article-title":"Fusion of the nucleoporin gene, NUP98, and the putative RNA helicase gene, DDX10, by inversion 11 (p15q22) chromosome translocation in a patient with etoposide-related myelodysplastic syndrome","volume":"39","author":"Nakao","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/382272a0","article-title":"Role for c-Abl tyrosine kinase in growth arrest response to DNA damage","volume":"382","author":"Yuan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2141.2000.02003.x","article-title":"Expression of the NUP98\/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15)","volume":"109","author":"Yamamoto","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1108>3.0.CO;2-9","article-title":"NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia","volume":"30","author":"Ahuja","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01901320","article-title":"Chromosome banding studies in 106 cases of chronic myelogenous leukemia","volume":"27","author":"Tomiyasu","year":"1982","journal-title":"Jinrui Idengaku Zasshi"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.1978.tb01104.x","article-title":"Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia","volume":"39","author":"Lilleyman","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-4608(81)90065-0","article-title":"Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia","volume":"3","author":"Hagemeijer","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib23","first-page":"1333","article-title":"The effect of imatinib mesylate on patients with Philadelphia chromosome\u2013positive chronic myeloid leukemia with secondary chromosomal aberrations","volume":"9","author":"Mohamed","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib24","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","article-title":"A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9","volume":"99","author":"Dash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib25","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2002-04-1244","article-title":"Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system","volume":"100","author":"Mayotte","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2004.06.014_bib26","first-page":"173","article-title":"BCR\/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia","volume":"2","author":"Salesse","year":"2003","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460804002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460804002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:49:01Z","timestamp":1759045741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460804002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0165460804002742"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2004.06.014","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal evolution with inv(11)(p15q22) and NUP98\/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics and Cytogenetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2004.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}